Cardiovascular Associates Of The Delaware Valley | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3	Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder	Recruiting	Phase 3	2026-10-07		NCT06716021
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention	Arterial Occlusive Diseases, Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, hyperlipidemia, metabolic disease, myocardial ischemia, vascular disorder	Recruiting	Phase 4	2026-10-05		NCT06909565
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation	Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder	Active, not recruiting	Phase 3	2026-09-25		NCT05757869
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias	Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, paroxysmal atrial fibrillation, persistent atrial fibrillation	Recruiting	Not stated	2026-09-22		NCT04088071
SyncAV Post-Market Trial	cardiovascular disorder, congestive heart failure, heart disorder, heart failure	Active, not recruiting	Not applicable	2025-12-18		NCT04100148
RADIANCE Continued Access Protocol	Hypertension Resistant to Conventional Therapy, cardiovascular disorder, essential hypertension, hypertensive disorder, vascular disorder	Active, not recruiting	Not applicable	2024-06-17		NCT05017935